NAD+ Supplement for Health Evaluation
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to study the absorption, safety, and effectiveness of an NAD+ supplement (Nicotinamide Adenine Dinucleotide) in healthy adults. Researchers seek to compare NAD+ levels in the blood after two months of supplement use versus a placebo. Participants will complete surveys, provide blood samples, and undergo heart and blood vessel health assessments. Individuals who are generally healthy and can maintain their lifestyle, including diet and exercise, without significant changes, are well-suited for this trial. As an unphased trial, this study allows participants to contribute to foundational research on NAD+ supplements and their potential health benefits.
Is there any evidence suggesting that the NAD+ supplement is likely to be safe for humans?
Research has shown that NAD+ supplements are generally safe for most people. Studies have found that these supplements can increase NAD+ levels in the body without causing serious side effects. Any side effects are usually mild and may occur more frequently with higher doses. Importantly, no reports of severe reactions, such as flushing or other major issues, have emerged.
While NAD+ supplements are safe for healthy adults, some individuals should exercise caution. Pregnant women and those with liver disease, active cancer, or diabetes should avoid these supplements unless advised otherwise by a doctor. Overall, evidence suggests that most people tolerate NAD+ supplements well.12345Why are researchers excited about this trial?
Nicotinamide Adenine Dinucleotide (NAD+) supplements are unique because they aim to boost cellular energy and repair by directly increasing NAD+ levels, which decline with age. Unlike other treatments that may focus on symptomatic relief, NAD+ plays a critical role in energy metabolism and mitochondrial function, potentially addressing root causes of aging-related health issues. Researchers are excited about this treatment because it offers a novel approach to promoting overall health and longevity by enhancing the body's natural processes at a cellular level.
What evidence suggests that this NAD+ supplement could be effective for improving NAD+ levels?
Research has shown that NAD+ supplements can safely raise NAD+ levels in the body. Studies have found that these supplements increase NAD+ levels in the blood within weeks. This is important because NAD+ levels typically decrease with age, weight gain, or high blood pressure. Some early research suggests that boosting NAD+ might improve heart health and reduce anxiety. However, while these supplements clearly raise NAD+ levels, their effects on long-term health and aging remain not fully understood. Participants in this trial will receive either the NAD+ supplement or a placebo to further evaluate these effects.12367
Are You a Good Fit for This Trial?
This trial is for healthy adults. People with any health conditions or on medications that could affect the study results are likely excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants consume either the NAD+ supplement or a placebo for 55 days and complete various assessments
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Nicotinamide Adenine Dinucleotide (NAD+) Supplement
Trial Overview
The study compares an oral NAD+ supplement to a placebo in healthy adults over about two months, measuring changes in blood NAD+ levels and checking safety and absorption.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Placebo Group
Participants will be instructed to take two capsules daily after breakfast starting on Day 1 (day following baseline visit) until the day prior to their end of study visit.
Participants will be instructed to take two capsules daily after breakfast starting on Day 1 (day following baseline visit) until the day prior to their end of study visit.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Reus Research
Lead Sponsor
KGK Science Inc.
Industry Sponsor
Najla Guthrie
KGK Science Inc.
Chief Executive Officer since 1997
Research career at the Centre for Human Nutrition, University of Western Ontario
Dr. Bibiane Zakaria
KGK Science Inc.
Chief Medical Officer since 2023
MD from an unspecified institution
Citations
Dietary Supplementation With NAD+-Boosting Compounds in ...
Supplementation with these compounds is safe, tolerable, and can increase the abundance of NAD+ and related metabolites in multiple tissues.
NAD⁺ supplementation for anti-aging and wellness
Overall, NAD⁺ augmentation shows clear biological activity, but clinical effectiveness for anti-aging or wellness outcomes remains inconclusive. Larger, well- ...
NAD+ Supplements: Can They Really Slow Down Aging?
They claim to boost energy and improve longevity, but there's currently not enough research to confirm these benefits.
Evaluation of safety and effectiveness of NAD in different ...
Based on studies, the supplementation with NADH and precursors was well tolerated and observed clinical results such as, a decrease in anxiety conditions and ...
NAD+ Metabolism in Cardiac Health, Aging, and Disease
NAD+ pools tend to decline with normal aging, obesity, and hypertension, NAD+ replenishment extends healthspan,
What You Need to Know About NAD+ Supplements
Children: Due to a lack of safety data in humans, NAD+ supplements are generally not recommended for children. That said, one long-term study ...
Current Uncertainties and Future Challenges Regarding ...
Currently there are no long-term human safety trials evaluating the safety of NAD+ boosters NR and NMN. Current data are based on small participant numbers
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.